Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 Earnings Call Transcript March 3, 2026
Arcturus Therapeutics Holdings Inc. misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.92.
Operator: Hello, and welcome, everyone, joining today’s Arcturus Therapeutics Fourth Quarter and Fiscal Year 2025 Earnings Call. [Operator Instructions] Please note this call is being recorded. And it is now my pleasure to turn the meeting over to Neda Safarzadeh, Vice...
